MAPT and Huntington disease: The primary objective of this study was to utilize the post-mortem brain tissue available from several transplanted HD patients in the Los Angeles trial to validate prior observations that mHtt and hyperphosphorylated tau can be detected in genetically unrelated grafted tissue in HD patients (Cicchetti et al., 2014; Cisbani et al., 2017).